Subscribe to Celia's posts
October 23rd, 2012
On September 25, our new Center for Science and Democracy held its inaugural Lewis M. Branscomb Science & Democracy Forum on “Improving Citizen Access to Government Scientific Information.” The event, which benefited from the generosity and vision of UCS member and eminent scientist Lewis M. Branscomb, was co-sponsored by the First Amendment Center in the Newseum’s spectacular seventh floor conference room, with a dazzling view of the Capitol and other Washington landmarks. Read More
June 29th, 2012
The news these days has rightly focused on the Supreme Court’s landmark decision on access to health care. But with scant media attention, Congress on June 26 sent a bill to the President that is just as important to the health and well-being of each and every American family, and the future of scientific integrity at the Food and Drug Administration. Read More
May 30th, 2012
We don’t know what we don’t know. For me, that’s the most shocking facet of our UCS report, A Climate of Corporate Control, released on May 30. Read More
May 10th, 2012
At last, a bit of good news and a glimmer of hope from Congress. Last Tuesday evening (May 8), the Senate unanimously approved S. 743, the Whistleblower Protection Enhancement Act. Read More
May 2nd, 2012
It is ironic that 50 years after the drug thalidomide was found to have caused serious harm to tens of thousands of babies in Europe and Great Britain, but not the U.S., both the Administration and Congress are backing efforts that could unravel the safety net and erode the power of American agencies to protect public health and safety. Read More
April 5th, 2012
It’s springtime in Washington, my favorite season in our nation’s capitol. The cherry blossoms have faded, but the bright red tulips are standing erect like soldiers in Lafayette Park, across from the White House. The streets are clogged with tourists and school groups, taking pictures, looking at the monuments, a bit dazzled by Washington’s beauty. Read More
March 29th, 2012
Any way you look at it, $700 million is a lot of cash. That’s the amount that industries regulated by the FDA have spent since 2009 lobbying Congress and the Executive Branch. That investment is paying off as Congress now considers must-pass legislation that governs how the FDA uses science to evaluate prescription drugs and medical devices. Read More
© 2013
